BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian germ cell tumor AND TP53, TRP53, 7157, ENSG00000141510, P04637, LFS1, P53
157 results:

  • 1. FGL2 promotes tumour growth and attenuates infiltration of activated immune cells in melanoma and ovarian cancer models.
    Galpin KJC; Rodriguez GM; Maranda V; Cook DP; Macdonald E; Murshed H; Zhao S; McCloskey CW; Chruscinski A; Levy GA; Ardolino M; Vanderhyden BC
    Sci Rep; 2024 Jan; 14(1):787. PubMed ID: 38191799
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Divergent Malignant Melanocytic Differentiation in ovarian Endometrioid Adenocarcinoma With Aberrant β-Catenin Expression: A Case Expanding the Histologic Spectrum of β-Catenin Activated Gynecologic Neoplasia.
    Xu J; Weisman PS
    Int J Gynecol Pathol; 2024 May; 43(3):302-307. PubMed ID: 37922945
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. ovarian squamous cell carcinoma associated with teratoma: a report of six cases with genomic analysis.
    Liang Y; Ruan H; Yu M; Lü B
    Pathology; 2023 Dec; 55(7):966-973. PubMed ID: 37739924
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The success rates of clinical cancer next-generation sequencing based on pathologic diagnosis: Experience from a single academic laboratory.
    Latham K; Dong F
    Am J Clin Pathol; 2023 Nov; 160(5):533-539. PubMed ID: 37543867
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. First case of endometrial cancer after yolk sac tumor in a patient with Li-Fraumeni syndrome.
    Ye QL; Qi Y; Liu JJ; Hu YX; Lv Y; Lin B
    BMC Womens Health; 2023 Jun; 23(1):329. PubMed ID: 37344881
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Immunity and reproduction protective effects of Chitosan Oligosaccharides in Cyclophosphamide/Busulfan-induced premature ovarian failure model mice.
    Li X; Ye H; Su T; Hu C; Huang Y; Fu X; Zhong Z; Du X; Zheng Y
    Front Immunol; 2023; 14():1185921. PubMed ID: 37228612
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
    Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
    Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Extrauterine Mesonephric-like Carcinoma: A Comprehensive Single Institution Study of 33 Cases.
    Euscher ED; Marques-Piubelli ML; Ramalingam P; Wistuba I; Lawson BC; Frumovitz M; Malpica A
    Am J Surg Pathol; 2023 Jun; 47(6):635-648. PubMed ID: 37026792
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Spatial genomic diversity associated with APOBEC mutagenesis in squamous cell carcinoma arising from ovarian teratoma.
    Tamura R; Nakaoka H; Yachida N; Ueda H; Ishiguro T; Motoyama T; Inoue I; Enomoto T; Yoshihara K
    Cancer Sci; 2023 May; 114(5):2145-2157. PubMed ID: 36762791
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ovarian Mucinous Carcinoma with a Yolk sac tumor-Like Component: A Report of Three Cases with a Literature Review for Prognostic Analysis.
    Tsujimura M; Fujimoto M; Minamiguchi S; Miyamoto T; Ueda A; Hamanishi J; Mandai M; Haga H
    Int J Surg Pathol; 2023 Aug; 31(5):765-771. PubMed ID: 36314449
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Molecular Evidence for Epithelial Origin of Mixed ovarian Epithelial-germ cell Neoplasms: Report of 2 Cases and Review of Literature.
    Hall KC; Post MD; Alldredge J; Aisner DL; Berning A
    Int J Gynecol Pathol; 2023 Jul; 42(4):403-413. PubMed ID: 36305517
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Neuroendocrine tumor of the Fallopian Tube and Serous Adenocarcinoma of the Ovary: Multicentric Primary tumors.
    Hyriavenko N; Lуndіn M; Sikora V; Chyzhma R; Lуndіna Y; Sikora K; Awuah WA; Romaniuk A
    Turk Patoloji Derg; 2023; 39(2):161-166. PubMed ID: 36178284
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. p53 Binding Sites in Long Terminal Repeat 5Hs (LTR5Hs) of Human Endogenous Retrovirus K Family (HML-2 Subgroup) Play Important Roles in the Regulation of LTR5Hs Transcriptional Activity.
    Liu M; Jia L; Li H; Liu Y; Han J; Wang X; Li T; Li J; Zhang B; Zhai X; Yu C; Li L
    Microbiol Spectr; 2022 Aug; 10(4):e0048522. PubMed ID: 35867400
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. BRCA1: An Endocrine and Metabolic Regulator.
    Werner H
    Front Endocrinol (Lausanne); 2022; 13():844575. PubMed ID: 35432218
    [TBL] [Abstract] [Full Text] [Related]  

  • 15.
    He Y; Rivera J; Diossy M; Duan H; Bowman-Colin C; Reed R; Jennings R; Novak J; Tran SV; Cohen EF; Szuts D; Giobbie-Hurder A; Bronson RT; Bass AJ; Signoretti S; Szallasi Z; Livingston DM; Pathania S
    Proc Natl Acad Sci U S A; 2021 Oct; 118(41):. PubMed ID: 34607954
    [No Abstract]    [Full Text] [Related]  

  • 16. The Role of Mutant p63 in Female Fertility.
    Luan Y; Xu P; Yu SY; Kim SY
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445673
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Mixed Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) of the Ovary Arising from Endometriosis: Molecular Pathology Analysis in Support of a Pathogenetic Paradigm.
    Maragliano R; Libera L; Carnevali I; Pensotti V; De Vecchi G; Testa M; Amaglio C; Leoni E; Formenti G; Sessa F; Furlan D; Uccella S
    Endocr Pathol; 2022 Sep; 33(3):400-410. PubMed ID: 34342838
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Analysis of the genomic landscape of yolk sac tumors reveals mechanisms of evolution and chemoresistance.
    Zong X; Zhang Y; Peng X; Cao D; Yu M; Wang J; Li H; Guo X; Liang H; Yang J
    Nat Commun; 2021 Jun; 12(1):3579. PubMed ID: 34117242
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The next generation sequencing of cancer-related genes in small cell neuroendocrine carcinoma of the cervix.
    Pei X; Xiang L; Chen W; Jiang W; Yin L; Shen X; Zhou X; Yang H
    Gynecol Oncol; 2021 Jun; 161(3):779-786. PubMed ID: 33888337
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. An aggressive systemic mastocytosis preceded by ovarian dysgerminoma.
    Tsutsumi M; Miura H; Inagaki H; Shinkai Y; Kato A; Kato T; Hamada-Tsutsumi S; Tanaka M; Kudo K; Yoshikawa T; Kurahashi H
    BMC Cancer; 2020 Nov; 20(1):1162. PubMed ID: 33246418
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 8.